Navigation Links
Aspirin Resistance Boosts Heart Risks in Cardiac Patients
Date:1/18/2008

They're four times more likely to suffer heart attack, stroke and even death, study finds

FRIDAY, Jan. 18 (HealthDay News) -- Heart patients who are resistant to aspirin are four times more likely to suffer a heart attack, stroke or to die, a new Canadian study says.

People who are aspirin-resistant have platelets -- the cells in blood responsible for clotting -- that aren't affected in the same way as platelets in people who respond to aspirin.

Publishing in the Jan. 18 online edition of the British Medical Journal, researchers at McMaster University Health Sciences Centre in Hamilton reviewed 20 studies that included 2,930 people with cardiovascular disease who'd been prescribed aspirin to prevent formation of blood clots. About 28 percent of the patients in the studies were aspirin-resistant.

The analysis revealed that 39 percent of aspirin-resistant patients suffered some sort of cardiovascular event, compared to 16 percent of other patients.

The researchers also found that other blood-thinning drugs, such as Clopidogrel or Tirofiban, did not provide any benefit to aspirin-resistant patients.

Currently, there is no agreed-upon method for identifying aspirin-resistant patients, and there is ongoing debate about why a person may be aspirin-resistant in the first place.

The authors of this latest study said more research is needed to figure out the best way to identify aspirin-resistant patients.

More information

The U.S. Food and Drug Administration has more about the use of aspirin to reduce stroke and heart attack risk.



-- Robert Preidt



SOURCE: British Medical Journal, news release, Jan. 18, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients
2. New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen
3. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
4. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
5. Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits
6. Overlooked Mutation Can Spur HIV Drug Resistance
7. HIV drug resistance risk in mothers reduced by combination of common drugs
8. Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies
9. Genetic approach provides new insight into trastuzumab resistance in breast cancer
10. Cell skeleton may hold key to overcoming drug resistance in cancer
11. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirin Resistance Boosts Heart Risks in Cardiac Patients
Aspirin Resistance Boosts Heart Risks in Cardiac Patients
Breaking Medicine Technology:Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 2Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 3Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 4Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 5Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 6Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 7Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 8Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 9Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 2Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 3New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 1New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 2New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 3New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 4New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 5New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 6New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 7New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 8New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 9New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 10New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 11New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 12New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 13New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 14New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 15New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 16New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 17New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 18New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 19New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 20New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 21New SIMPONI 28TM 29 Data Show Long Term Efficacy in Treatment of Rheumatoid Arthritis 14525 22Hologic Expands Healthcare Investment in Asia 5563 1Hologic Expands Healthcare Investment in Asia 5563 2Hologic Expands Healthcare Investment in Asia 5563 3ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 1ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 2